# Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.

Study · id `cardio:ct-nct06249347` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06249347](<https://clinicaltrials.gov/study/NCT06249347>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06249347

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 166 participants.

## Technical summary

Registry record NCT06249347. Randomized; single masking; primary purpose treatment. Start 2024-01-28 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 166 participants (planned count; ClinicalTrials.gov record NCT06249347, source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)
- Started: 2024-01-28 (actual) (ClinicalTrials.gov record NCT06249347, source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06249347, source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06249347, source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06249347, source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06249347-2024-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.
- Condition: Atrial Fibrillation
- Condition: Atrial Fibrillation, Persistent
- Intervention (Procedure): PROMISED
- Intervention (Procedure): CPVI and LAAC
- Intervention (Device): Radiofrequency ablation catheter
- Intervention (Device): left atrial appendage occlusion device
- Lead sponsor: Second Affiliated Hospital of Wenzhou Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital of Wenzhou Medical University (`cardio:org-second-affiliated-hospital-of-wenzhou-medical-university`)

## Provenance

Content hash: 178af6ce8446decf1dd7348ae9c19cfa893eef13891e9a6fd5687bb4e9cd2f77
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
